Maya Martinez-Davis
Corporate Officer/Principal chez GSK PLC
Postes actifs de Maya Martinez-Davis
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01/01/2020 | - |
Historique de carrière de Maya Martinez-Davis
Anciens postes connus de Maya Martinez-Davis
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MIRATI THERAPEUTICS | Director/Board Member | 06/12/2018 | 23/01/2024 |
| Independent Dir/Board Member | 06/12/2018 | 23/01/2024 | |
| MERCK KGAA | Corporate Officer/Principal | 01/01/2016 | 01/08/2019 |
Formation de Maya Martinez-Davis
| St. Louis University | Undergraduate Degree |
| Instituto de Empresa SL | Graduate Degree |
Statistiques
Internationale
| Espagne | 3 |
| Allemagne | 2 |
| Royaume-Uni | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MERCK KGAA | Health Technology |
| GSK PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Maya Martinez-Davis
- Expérience
